Skip to content

SANTEL

Active
Private limited companyfounded 20215 yrs activeRue de Moncheret(ACO) 79, 6280 Gerpinnes, BelgiumKBO/BCE: BE 0762.631.519
Summary

SANTEL has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €106,384 and a net result of €34,510. Equity is growing by ~30.5% per year across the filed fiscal years. Its solvency ranks better than 82% of 20110 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€146,637total assets 2025
Equity
€106,384
Profit
€34,510
Turnover not published (abridged schema)
Financial health
89 Excellent Checked score 2025
Bankruptcy chance 12 m
0.3%
Structure
Accounts 43 d early0 of 2 deeds read
Why 89- 1 change of registered office in 24 months- Founded in 2021+ Liquidity: current ratio 6.11, cash €88,255+ Equity €106,384 (72.5% of total assets)Show the evidence

Checked score

Score 2025
89 / 100
Excellent
Probability in this band: under 0.55%
Better than 75% of its sector peers (NACE 47, micro)
Performance against the sector, not lower risk
Financial strength · tick = 2024
Strong
Solvency 98-2
equity 72.5% of total assets
Liquidity 99=
short-term debt 12.3% · cash 60.2%
Profitability 98=
return on assets 23.5%
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.7% (39,898 companies)
Last 5 months 06-2026: 0.3%highest value 07-2026: 0.3%▼ -4.8% vs 06-2026 08-2026: 0.3%▲ +3.1% vs 07-2026 09-2026: 0.3%● 0.0% vs 08-2026 10-2026: 0.3%▼ -3.9% vs 09-2026lowest value
  • Liquidity: current ratio 6.11, cash €88,255 lowers the probability
  • 1 change of registered office in 24 months raises the probability
  • Founded in 2021 raises the probability for this profile
  • Equity €106,384 (72.5% of total assets) lowers the probability
Credit up to €9,000 at 30 days acceptable
Liquidity ample (current ratio 6.11 against 9.05 in 2024; short-term debt: 12.3% and cash: 60.2% of total assets), and 27.5% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 47, micro). Better than this share of them on solvency 83%, liquidity 96%, profitability 91%, growth against the median 31%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 02-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Liquidity: current ratio 6.11, cash €88,255
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
raises risk · 1 change of registered office in 24 months
In the bankruptcy model this factor raises the probability.
Belgian State Gazette
raises risk · Founded in 2021
In the bankruptcy model this factor raises the probability for this profile.
KBO
lowers risk · Equity €106,384 (72.5% of total assets)
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-06-2026, 43 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
43 d early
2024
21 d early
2023
7 d late
2022
on the day
2021
4 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 5 accounts on average 11 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 31 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
02-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · micro…
  2. Annual accounts filedfiscal year 2024 · micro…
  3. Equity above €100,000Eq €111,874 ▲36.1%

Key points

  • Positive: Among the best 18% on net resultsector median €5,003 · 20,084 companies €34,510 View
  • Positive: 5 profitable years in a rowprofit 2025: €34,510 5 years View
  • Total assets 20255 fiscal years filed €146,637 View

By topic

Financials

Fiscal year
2025
Total assets
€146,637
Profit
€34,510
Solvency
72.5%
Total assets▲ 16.8%
Net result
20212025
Go to Financials

Timeline

Events
8
Since
2022
Next accounts
by 31-07-2027
  1. 18-06-2026Annual accounts filed
  2. 10-07-2025Annual accounts filed
  3. 31-12-2024Equity above €100,000
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
28-01-2021
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.